Daewoong pharmaceutical

069620.KO

95.74 USD

-2.56

-2.60%

Overview

Last close

95.74 usd

Market cap

1.10B usd

52 week high

119.39 usd

52 week low

72.15 usd

Target price

134.03 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.1366

Price/Book Value

1.9835

Enterprise Value

1.46B usd

EV/Revenue

1.4848

EV/EBITDA

12.656

Key financials

Revenue TTM

972.71M usd

Gross Profit TTM

491.67M usd

EBITDA TTM

121.72M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

1.46B usd

Net debt

N/A usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.